DABRA - search results
If you're not happy with the results, please do another search
Ra Medical Systems receives FDA 510(k) clearance for the Dabra 2.0 catheter
Ra Medical Systems has announced receipt of US Food and Drug Administration (FDA) 510(k) clearance for the company’s Dabra 2.0 catheter as part of...
Ra Medical Systems announces 10 subjects have been enrolled in its DABRA trial
Ra Medical Systems has announced enrolment of the tenth subject in its pivotal clinical trial to evaluate the safety and effectiveness of the Dabra...
Ra Medical clinical study aims to show DABRA keeps arteries healthy longer
Ra Medical is conducting a study to demonstrate the DABRA Excimer Laser System delivers effective, long lasting results and a low reintervention rate for...
New study shows 94% success rate for DABRA laser system achieved in PAD patients
Ra Medical Systems has announced study results from Athar Ansari, director of the California Heart & Vascular Clinic in El Centro, USA. The study...
Ra Medical Systems granted broad patent for DABRA catheter
The US Patent and Trademark Office has granted Ra Medical Systems a broad patent (number 9700655) that covers Ra Medical Systems’ DABRA catheter for...
First commercial use of Ra Medical Systems’ DABRA takes place in USA
The Heart Endovascular & Rhythm of Texas announced its latest collaboration with Ra Medical Systems to use the Destruction of Arteriosclerotic Blockages by laser...
Ra Medical Systems receives US FDA clearance for DABRA peripheral artery disease treatment
The US Food and Drug Administration (FDA) has granted market clearance to Ra Medical Systems—makers of excimer lasers and catheters for cardiovascular and dermatological...
Ra Medical Systems receives European approval for DABRA atherectomy and Pharos laser phototherapy systems
Ra Medical Systems has received CE mark approval for both the DABRA atherectomy system with catheter and the Pharos excimer laser to treat psoriasis,...
Vascular News’ top 10 most popular stories of July 2022
July's top 10 most popular items include more from this year's Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM 2022; 15–18 June, Boston,...
Ra Medical Systems reaches 100 enrolled subjects in pivotal atherectomy clinical study
Ra Medical Systems has announced the achievement of a milestone with the enrollment of 100 subjects in the pivotal clinical study, according to a...
Ra Medical Systems provides update on enrolment in pivotal atherectomy clinical trial
Ra Medical Systems recently announced that enrolment has reached 95 patients in its pivotal clinical trial to evaluate the safety and effectiveness of the...
Ra Medical Systems announces enrolment of first patient in pivotal atherectomy clinical study
Ra Medical Systems has announced enrolment of the first patient in its pivotal study to evaluate the safety and effectiveness of the DABRA excimer...
Ra Medical Systems receives FDA IDE approval to begin pivotal atherectomy clinical study
Ra Medical Systems has announced approval from the US Food and Drug Administration (FDA) that the company has provided sufficient data to support initiating...
Peripheral and Aortic Workshops give CX delegates practical experience and expert discussion
During the CX Peripheral and Aortic Workshops at the 2019 Charing Cross Symposium (London, UK), experts demonstrated a wide range of peripheral and aortic...
Ra Medical files statement for proposed initial public offering
Ra Medical Systems has filed a registration statement on Form S-1 with the US Securities and Exchange Commission relating to a proposed initial public...
Ra Medical Systems names Maurice Buchbinder and Martin Colombatto to board of directors
Following the €1.9 billion (US$2.16 billion) purchase of The Spectranetics Corporation by Royal Philips, Ra Medical Systems has announced the appointment of two new...
Ra Medical Systems launches catheters and lasers in Northern Europe
Ra Medical Systems and bo medical technologies, have announced the launch of the Dabra atherectomy system for cardiovascular and Pharos excimer laser for dermatology...
